212 related articles for article (PubMed ID: 35780401)
21. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
[TBL] [Abstract][Full Text] [Related]
22. Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.
Agarwal R; Rajanbabu A; Nair IR; Satish C; Jose G; Unikrishnan UG
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():92-97. PubMed ID: 28738297
[TBL] [Abstract][Full Text] [Related]
23. Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma.
Davidson B; Hellesylt E; Holth A; Danielsen HE; Skeie-Jensen T; Katz B
Virchows Arch; 2017 Sep; 471(3):355-362. PubMed ID: 28643014
[TBL] [Abstract][Full Text] [Related]
24. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
25. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.
Nasioudis D; Chapman-Davis E; Frey M; Holcomb K
J Gynecol Oncol; 2017 Jul; 28(4):e46. PubMed ID: 28541635
[TBL] [Abstract][Full Text] [Related]
26. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
[TBL] [Abstract][Full Text] [Related]
27. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
[TBL] [Abstract][Full Text] [Related]
28. Systemic treatment in adult uterine sarcomas.
Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
[TBL] [Abstract][Full Text] [Related]
29. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
[TBL] [Abstract][Full Text] [Related]
30. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
[TBL] [Abstract][Full Text] [Related]
31. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
32. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
[TBL] [Abstract][Full Text] [Related]
33. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study.
Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K
Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic features and prognostic factors of endometrial stromal sarcoma: a study of 55 cases].
Shi JL; Cheng NH; Guo LN; Lian LJ
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):517-22. PubMed ID: 22169638
[TBL] [Abstract][Full Text] [Related]
35. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review.
Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
[TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
Gao Y; Meng H; Zhang Y; Jiao T; Hui N
Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
[TBL] [Abstract][Full Text] [Related]
37. Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.
Stewart LE; Beck TL; Giannakopoulos NV; Rendi MH; Isacson C; Goff BA
Gynecol Oncol; 2018 May; 149(2):297-300. PubMed ID: 29534832
[TBL] [Abstract][Full Text] [Related]
38. How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?
Rovirosa A; Ascaso C; Ordi J; Arenas M; Valduvieco I; Lejarcegui JA; Pahisa J; Torne A; Biete A
Clin Transl Oncol; 2009 Oct; 11(10):681-7. PubMed ID: 19828411
[TBL] [Abstract][Full Text] [Related]
39. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
[TBL] [Abstract][Full Text] [Related]
40. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
